Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

被引：0

作者：

Bourlon, Christianne ^{[1
]}

Roddie, Claire ^{[2
,3
]}

Menne, Tobias ^{[4
]}

Norman, Jane ^{[5
]}

O'Reilly, Maeve ^{[2
]}

Gibb, Adam ^{[6
]}

Besley, Caroline ^{[7
]}

Chaganti, Sridhar ^{[8
]}

Arias, Carlos Gonzalez ^{[9
]}

Jones, Ceri ^{[10
]}

Dikair, Abdalla ^{[11
]}

Allen, Sharon ^{[12
]}

Seymour, Frances ^{[13
]}

Osborne, Wendy ^{[4
]}

Mathew, Amrith ^{[8
]}

Townsend, William ^{[2
]}

Patten, Piers E. M. ^{[1
,14
]}

Thoulouli, Eleni ^{[5
]}

Abdulgawad, Ahmed ^{[15
]}

Lugthart, Sanne ^{[7
]}

Sanderson, Robin ^{[1
]}

Kirkwood, Amy A. ^{[16
]}

Kuhnl, Andrea ^{[1
]}

机构：

[1] Kings Coll Hosp London, Dept Hematol, London, England

[2] Univ Coll London Hosp, Dept Hematol, London, England

[3] UCL, UCL Canc Inst, London, England

[4] Newcastle Univ, Freeman Hosp, Dept Hematol, Newcastle, England

[5] Manchester Royal Infirm, Dept Hematol, Manchester, England

[6] Christie Hosp, Dept Med Oncol, Manchester, England

[7] Univ Hosp Bristol & Weston, Dept Hematol, Bristol, England

[8] Queen Elizabeth Hosp, Dept Hematol, Birmingham, England

[9] Royal Marsden Hosp, Dept Hematol, London, England

[10] Univ Hosp Wales, Dept Hematol, Cardiff, England

[11] Queen Elizabeth Hosp, Dept Hematol, Glasgow, Scotland

[12] Cambridge Univ Hosp, Dept Hematol, Cambridge, England

[13] Leeds Teaching Hosp, Dept Hematol, Leeds, England

[14] Kings Coll London, Comprehens Canc Ctr, London, England

[15] Christie Hosp, Dept Hematol, Manchester, England

[16] UCL, UCL Canc Inst, CR UK & UCL Canc Trials Ctr, London, England

来源：

HAEMATOLOGICA | 2024年 / 109卷 / 08期

关键词：

D O I：

10.3324/haematol.2024.285010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2716 / 2720

页数：5

共 50 条

[21] Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
Seyedin, Roxanna
Snider, Julia T.
Rajagopalan, Krithika
Wade, Sally W.
Gergis, Usama
FUTURE ONCOLOGY, 2023, 19 (22) : 1535 - 1547
[22] Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience
Trando, Aaron
Ter-Zakarian, Anna
Yeung, Phillip
Goodman, Aaron M.
Hamdan, Ayad
Hurley, Michael
Jeong, Ah-Reum
Tzachanis, Dimitrios
CANCERS, 2023, 15 (18)
[23] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Yin, Zixun
Zhang, Ya
Wang, Xin
BIOMARKER RESEARCH, 2021, 9 (01)
[24] Cytomegalovirus impact in b-cell lymphoma patients treated with chimeric antigen receptor t-cell therapy
Marquez-Algaba, E.
Pernas, B.
Esperalba, J.
Los-Arcos, I.
Carpio, C.
Iacoboni, G.
Barba, P.
Ruiz-Camps, I.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 134 - 134
[25] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Zixun Yin
Ya Zhang
Xin Wang
Biomarker Research, 9
[26] Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
Hu, Bei
Korsos, Victoria
Palomba, M. Lia
FRONTIERS IN ONCOLOGY, 2024, 14
[27] Response to Bridging Therapy As a Predictor of Outcomes for Chimeric Antigen Receptor Therapy in Large B-Cell Lymphoma
Khurana, Arushi
Hathcock, Matthew
Bansal, Radhika
Wang, Yucai
Paludo, Jonas
Villasboas, Jose C.
Bennani, N. Nora
Johnston, Patrick B.
Ansell, Stephen M.
Lin, Yi
BLOOD, 2021, 138 : 3841 - +
[28] Impact of Extranodal Involvement on Outcomes with Chimeric Antigen Receptor T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma
Kumar, Vinod
Alotaibi, Shaykhah
Li, Zhuo
Ayala, Ernesto
Kharfan-Dabaja, Mohamed A.
Iqbal, Madiha
BLOOD, 2024, 144 : 5129 - 5130
[29] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
Lin, John K.
Muffly, Lori S.
Spinner, Michael A.
Barnes, James, I
Owens, Douglas K.
Goldhaber-Fiebert, Jeremy D.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
[30] Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
Howell, Timothy A.
Matza, Louis S.
Jun, Monika P.
Garcia, Jacob
Powers, Annette
Maloney, David G.
PHARMACOECONOMICS-OPEN, 2022, 6 (03) : 367 - 376

← 1 2 3 4 5 →